85 related articles for article (PubMed ID: 12458328)
1. Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma.
de la Haba-Rodríguez J; Macho A; Calzado MA; Blázquez MV; Gómez MA; Muñoz EE; Aranda E
Neoplasma; 2002; 49(5):307-11. PubMed ID: 12458328
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.
Cordero OJ; Ayude D; Nogueira M; Rodriguez-Berrocal FJ; de la Cadena MP
Br J Cancer; 2000 Nov; 83(9):1139-46. PubMed ID: 11027426
[TBL] [Abstract][Full Text] [Related]
3. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
[TBL] [Abstract][Full Text] [Related]
4. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
5. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018
[TBL] [Abstract][Full Text] [Related]
6. CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia.
de Andrade CF; Bigni R; Pombo-de-Oliveira MS; Alves G; Pereira DA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):708-14. PubMed ID: 19469710
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
8. Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease.
Detel D; Persić M; Varljen J
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):65-70. PubMed ID: 17592366
[TBL] [Abstract][Full Text] [Related]
9. Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116.
Kawasaki N; Lin CW; Inoue R; Khoo KH; Kawasaki N; Ma BY; Oka S; Ishiguro M; Sawada T; Ishida H; Hashimoto T; Kawasaki T
Glycobiology; 2009 Apr; 19(4):437-50. PubMed ID: 19129245
[TBL] [Abstract][Full Text] [Related]
10. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
11. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
[TBL] [Abstract][Full Text] [Related]
13. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
14. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
[TBL] [Abstract][Full Text] [Related]
15. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum dipeptidyl peptidase IV activity in patients with chronic tonsillitis.
Vlahović P; Avramović V; Stanković M; Savić S; Todorović M
Ann Clin Biochem; 2007 Jan; 44(Pt 1):70-4. PubMed ID: 17270095
[TBL] [Abstract][Full Text] [Related]
18. Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors.
Erić-Nikolić A; Matić IZ; Dorđević M; Milovanović Z; Marković I; Džodić R; Inić M; Srdić-Rajić T; Jevrić M; Gavrilović D; Cordero OJ; Juranić ZD
Immunobiology; 2011 Aug; 216(8):942-6. PubMed ID: 21281985
[TBL] [Abstract][Full Text] [Related]
19. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
Shibuya-Saruta H; Kasahara Y; Hashimoto Y
J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
